The ongoing enigma of tight glucose control

The Lancet

Volumn 373, Issue 9663, 2009, Pages 520-521

  Levy, Mitchell M ^a   Rhodes, Andrew ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN;

ARTICLE; CLINICAL PROTOCOL; CONSENSUS DEVELOPMENT; CRITICALLY ILL PATIENT; DEATH; DIAGNOSTIC ACCURACY; DISEASE MARKER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; LONG TERM CARE; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY INFECTION;

EID: 59749084333     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60045-3     Document Type: Note

References (14)

1. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
2. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
3. Sprung C.L., Annane D., Keh D., et al., for the CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008) 111-124
4. Abraham E., Laterre P.F., Garg R., et al., for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353 (2005) 1332-1341
5. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 130 (2006) 1579-1595
6. Srinivasan V., Spinella P.C., Drott H.R., et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 5 (2004) 329-336
7. Vanhorebeek I., Langouche L., and Van den Berghe G. Tight blood glucose control: what is the evidence?. Crit Care Med 35 suppl 9 (2007) S496-S502
8. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
9. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
10. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
11. Brunkhorst F.M., Engel C., Bloos F., et al., for the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008) 125-139
12. Arabi Y.M., Dabbagh O.C., Tamim H.M., et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36 (2008) 3190-3197
13. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet (2009) 10.1016/S0140-6736(09)60044-1 published online Jan 27.
14. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign. International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008) 296-327